title: HER2 amplification status in gastric and gastro-oesophageal junction cancer in routine clinical practice: which sample should be used?
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Perrone
authors.forename: Michelina
authors.initials: M
authors.lastname: Amato
authors.forename: Marcella
authors.initials: M
authors.lastname: Callea
authors.forename: Carla
authors.initials: C
authors.lastname: Rabitti
authors.forename: Daniela
authors.initials: D
authors.lastname: Righi
authors.forename: Pierfilippo
authors.initials: P
authors.lastname: Crucitti
authors.forename: Roberto
authors.initials: R
authors.lastname: Coppola
authors.forename: Andrea
authors.initials: A
authors.lastname: Onetti Muda
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism / Q000556:secondary; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D004943:Esophagogastric Junction; D005784:Gene Amplification; D006801:Humans; D007150:Immunohistochemistry; D009362:Neoplasm Metastasis / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics* / Q000378:metabolism; D015203:Reproducibility of Results; D013048:Specimen Handling / Q000379:methods*; D013274:Stomach Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D000068878:Trastuzumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab